Ground Swell Capital’s ImmuCell ICCC Stock Holding History

Ground Swell Capital’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2K	Sell	395 -112	-22%	-$524	﹤0.01%	1903
2014 Q2	$2K	Buy	+507	New	+$2.13K	﹤0.01%	1492

Other funds holding ICCC

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Ground Swell Capital's ICCC Position: Q3 2014 in Review

Ground Swell Capital reduced its ImmuCell (ICCC) stake by 22% in Q3 2014, selling an estimated $524 and leaving 395 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Ground Swell Capital first reported a position in ICCC in Q2 2014 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold ICCC as of Q3 2014.

Ground Swell Capital held 395 shares of ImmuCell worth $2K as of Q3 2014.
Ground Swell Capital sold 112 ImmuCell shares in Q3 2014, an estimated $524.
ImmuCell made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1903 holding.
Ground Swell Capital first reported a position in ImmuCell in Q2 2014 and has held it in 2 quarters since.
13 funds tracked by Wall St. Rank held ImmuCell as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.